2,2,5,7,8-pentamethyl-1-hydroxychroman has been researched along with Hemolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pekiner, B; Pennock, JF | 1 |
| Koga, T; Moro, K; Terao, J | 1 |
2 other study(ies) available for 2,2,5,7,8-pentamethyl-1-hydroxychroman and Hemolysis
| Article | Year |
|---|---|
Oxidation of human red blood cells by a free radical initiator and effects of radical scavengers.
Topics: Antioxidants; Azo Compounds; Chromans; Erythrocytes; Free Radical Scavengers; Free Radicals; Hemolysis; Humans; Liposomes; Oxidation-Reduction; Phosphatidylcholines; Structure-Activity Relationship; Valerates; Vitamin E | 1994 |
Protective effect of a vitamin E analog, phosphatidylchromanol, against oxidative hemolysis of human erythrocytes.
Topics: Amidines; Antioxidants; Butylated Hydroxytoluene; Chromans; Erythrocyte Membrane; Erythrocytes; Free Radicals; Glycerophospholipids; Hemolysis; Humans; In Vitro Techniques; Oxidants; Oxidation-Reduction; Phosphatidic Acids; Probucol; Vitamin E | 1998 |